The Mary Kay Ash Foundation Cancer Research Grant 2027 provides up to US$100,000 over two years for translational research on cancers affecting women. The programme covers breast, ovarian, cervical, uterine and other cancers affecting women.
The foundation seeks projects that connect laboratory findings to clinical questions, with the potential to improve cancer prevention, diagnosis, prognosis or treatment. The programme is by institutional invitation, and each invited institution can submit only one proposal. Researchers should check with their grants office for the internal selection deadline.
Eligibility Criteria
- The foundation invites NCI-designated cancer institutes and accredited medical schools to apply.
- Institutions seeking an invitation must undergo review by the Research Review Committee chair and receive approval from the foundation’s board.
- Each invited institution may submit only one application.
- The proposed project must focus on a cancer affecting women.
- The research must have a clear translational aim, connecting laboratory work with a potential clinical application.
Funding Details
- Maximum award: US$100,000, including direct and indirect costs.
- Duration: Two years.
- Number of awards: The foundation typically expects to fund 10–15 projects annually.
Deadline
- Sponsor deadline: February 1, 2027.
- Internal deadlines: Vary by institution and may be earlier than the sponsor deadline.
- Applicant notifications: August 2027, according to the foundation’s published annual schedule.